English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Direct generation of human naive induced pluripotent stem cells from somatic cells in microfluidics

Giulitti, S., Pellegrini, M., Zorzan, I., Martini, P., Gagliano, O., Mutarelli, M., et al. (2019). Direct generation of human naive induced pluripotent stem cells from somatic cells in microfluidics. NATURE CELL BIOLOGY, 21(2), 275-286. doi:10.1038/s41556-018-0254-5.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Giulitti, Stefano, Author
Pellegrini, Marco, Author
Zorzan, Irene, Author
Martini, Paolo, Author
Gagliano, Onelia, Author
Mutarelli, Margherita, Author
Ziller, Michael Johannes1, Author           
Cacchiarelli, Davide, Author
Romualdi, Chiara, Author
Elvassore, Nicola, Author
Martello, Graziano, Author
Affiliations:
1RG Genomics of Complex Diseases, Max Planck Institute of Psychiatry, Max Planck Society, ou_3008285              

Content

show
hide
Free keywords: -
 Abstract: Induced pluripotent stem cells (iPSCs) are generated via the expression of the transcription factors OCT4 (also known as POU5F1), SOX2, KLF4 and cMYC (OSKM) in somatic cells. In contrast to murine naive iPSCs, conventional human iPSCs are in a more developmentally advanced state called primed pluripotency. Here, we report that human naive iPSCs (niPSCs) can be generated directly from fewer than 1,000 primary human somatic cells, without requiring stable genetic manipulation, via the delivery of modified messenger RNAs using microfluidics. Expression of the OSKM factors in combination with NANOG for 12 days generates niPSCs that are free of transgenes, karyotypically normal and display transcriptional, epigenetic and metabolic features indicative of the naive state. Importantly, niPSCs efficiently differentiate into all three germ layers. While niPSCs can be generated at low frequency under conventional conditions, our microfluidics approach enables the robust and cost-effective production of patient-specific niPSCs for regenerative medicine applications, including disease modelling and drug screening.

Details

show
hide
Language(s):
 Dates: 2019
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: ISI: 000457468300020
DOI: 10.1038/s41556-018-0254-5
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: NATURE CELL BIOLOGY
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 21 (2) Sequence Number: - Start / End Page: 275 - 286 Identifier: ISSN: 1465-7392